FDA Approves Pioneering Gene Therapy for Rare Childhood Deafness

FDA Approves Pioneering Gene Therapy for Rare Childhood Deafness

The Approval Transforms Options for Affected Families The Food and Drug Administration approved Regeneron's Otarmeni on Thursday, marking the first ge...